Takeda Pharmaceutical Company Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2025 | 13.40 M | $196.24 M | 0.82% | 0.43% |
| MORGAN STANLEY | 11/14/2025 | 7.69 M | $112.59 M | 0.93% | 0.25% |
| UBS GROUP AG | 11/13/2025 | 5.89 M | $86.29 M | 46.45% | 0.19% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 4.95 M | $72.52 M | 10.05% | 0.16% |
| FMR LLC | 11/13/2025 | 4.19 M | $61.30 M | 2.08% | 0.13% |
| BRANDES INVESTMENT PARTNERS, LP | 11/14/2025 | 3.93 M | $57.56 M | 5.91% | 0.13% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 3.86 M | $56.58 M | 17.14% | 0.12% |
| BLACKROCK, INC. | 11/12/2025 | 3.31 M | $48.42 M | -6.85% | 0.11% |
| TORONTO DOMINION BANK | 11/14/2025 | 3.00 M | $43.98 M | 100.00% | 0.10% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 11/13/2025 | 2.83 M | $41.41 M | 132.12% | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 2.56 M | $37.42 M | -17.24% | 0.08% |
| FIRST TRUST ADVISORS LP | 11/12/2025 | 2.52 M | $36.86 M | -3.24% | 0.08% |
| NORTHERN TRUST CORP | 11/14/2025 | 1.82 M | $26.70 M | -10.16% | 0.06% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 1.78 M | $26.00 M | 407.88% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.61 M | $23.55 M | 89.06% | 0.05% |
| MANAGED ASSET PORTFOLIOS, LLC | 11/12/2025 | 1.49 M | $21.76 M | -0.16% | 0.05% |
| VAN ECK ASSOCIATES CORP | 11/13/2025 | 1.16 M | $17.02 M | -12.70% | 0.04% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 1.03 M | $15.14 M | 2.10% | 0.03% |
| QUANTINNO CAPITAL MANAGEMENT LP | 11/14/2025 | 973.86 K | $14.26 M | 22.18% | 0.03% |
| ENVESTNET ASSET MANAGEMENT INC | 11/05/2025 | 866.61 K | $12.69 M | -1.51% | 0.03% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 766.28 K | $11.22 M | 107.59% | 0.02% |
| CROSSMARK GLOBAL HOLDINGS, INC. | 11/12/2025 | 727.23 K | $10.65 M | 0.01% | 0.02% |
| ABC ARBITRAGE SA | 11/06/2025 | 571.86 K | $8.37 M | 100.00% | 0.02% |
| STIFEL FINANCIAL CORP | 11/12/2025 | 508.92 K | $7.45 M | 12.09% | 0.02% |
| ROYAL BANK OF CANADA | 11/14/2025 | 489.39 K | $7.17 M | 5.28% | 0.02% |
| NATIXIS ADVISORS, L.P. | 11/13/2025 | 480.37 K | $7.03 M | 5.92% | 0.02% |
| CREATIVE PLANNING | 11/14/2025 | 463.39 K | $6.78 M | 24.55% | 0.01% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 398.97 K | $5.84 M | 11.75% | 0.01% |
| FEDERATED HERMES, INC. | 11/03/2025 | 398.39 K | $5.83 M | -25.40% | 0.01% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 385.76 K | $5.65 M | 7.74% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 368.35 K | $5.39 M | -64.48% | 0.01% |
| BLEAKLEY FINANCIAL GROUP, LLC | 11/10/2025 | 362.31 K | $5.30 M | 0.82% | 0.01% |
| ETHIC INC. | 10/17/2025 | 310.75 K | $4.55 M | 16.19% | 0.01% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 281.29 K | $4.12 M | 100.00% | 0.01% |
| QRG CAPITAL MANAGEMENT, INC. | 10/28/2025 | 281.14 K | $4.12 M | -35.02% | 0.01% |
| CLEAN YIELD GROUP | 10/23/2025 | 266.04 K | $3.89 M | -3.26% | 0.01% |
| HANTZ FINANCIAL SERVICES, INC. | 11/05/2025 | 260.17 K | $3.81 M | 14.49% | 0.01% |
| LPL FINANCIAL LLC | 11/12/2025 | 252.18 K | $3.69 M | 11.86% | 0.01% |
| MARINER, LLC | 11/14/2025 | 248.97 K | $3.64 M | -7.71% | 0.01% |
| JPMORGAN CHASE & CO | 11/26/2025 | 247.53 K | $3.62 M | 37.70% | 0.01% |
| PATHSTONE HOLDINGS, LLC | 11/13/2025 | 238.34 K | $3.49 M | 7.43% | 0.01% |
| MANNING & NAPIER ADVISORS LLC | 10/27/2025 | 226.44 K | $3.32 M | -7.67% | 0.01% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 221.52 K | $3.24 M | 597.05% | 0.01% |
| CETERA INVESTMENT ADVISERS | 11/14/2025 | 213.22 K | $3.12 M | 186.19% | 0.01% |
| MERCER GLOBAL ADVISORS INC /ADV | 11/14/2025 | 212.60 K | $3.11 M | -5.61% | 0.01% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 207.20 K | $3.03 M | 35.87% | 0.01% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 203.81 K | $2.98 M | 362.10% | 0.01% |
| XY CAPITAL LTD | 11/14/2025 | 200.03 K | $2.93 M | 100.00% | 0.01% |
| SEI INVESTMENTS CO | 11/13/2025 | 193.30 K | $2.83 M | 20.86% | 0.01% |
| CATALYST CAPITAL ADVISORS LLC | 11/12/2025 | 185.00 K | $2.71 M | 2.21% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Takeda Pharmaceutical Company Limited institutional Ownership - FAQ's
During the previous two years, 478 institutional investors and hedge funds held shares of Takeda Pharmaceutical Company Limited. The most heavily invested institutionals were:
Capital Research Global Investors: 13.4 M
MORGAN STANLEY: 7.69 M
UBS Group AG: 5.89 M
GOLDMAN SACHS GROUP INC: 4.95 M
FMR LLC: 4.19 M
BRANDES INVESTMENT PARTNERS, LP: 3.93 M
2.72% of Takeda Pharmaceutical Company Limited stock is owned by institutional investors.
Institutional investors have bought a total of 104.65 M shares in the last 24 months. This purchase volume represents approximately $1.53 B in transactions.